Biomarkers
rheumatoid
The changes in IgG and IgM levels from baseline to week 12 were numerically greater in the TAS5315 groups than the placebo group (Change over time to week 36 in levels of (A) IgG, (B) IgM, (C) rheumatoid factor (RF) and (D) anticyclic citrullinated protein antibody (ACPA).